Literature DB >> 11435848

Transurethral prostatic resection or laser therapy for men with acute urinary retention: the ClasP randomized trial.

K N Chacko1, J L Donovan, P Abrams, T J Peters, S T Brookes, A C Thorpe, S Gujral, M Wright, L G Kennedy, D E Neal.   

Abstract

PURPOSE: Transurethral resection of the prostate is the standard operation for acute urinary retention, although laser prostatectomy is reportedly effective and safe. The ClasP (conservative management, laser, transurethral resection of the prostate) study compared transurethral prostatic resection and noncontact neodymium (Nd):YAG visual laser assisted prostatectomy for treatment of acute urinary retention.
MATERIALS AND METHODS: This study was a multicenter randomized controlled trial, analyses were by intention to treat and followup was at 7.5 months after randomization. Primary outcomes were treatment failure, and included International Prostate Symptom Score, International Prostate Symptom Score quality of life score, residual urine and flow rate. Secondary outcomes included complications, and duration of catheterization and hospitalization.
RESULTS: A total of 148 men were randomized to transurethral prostatic resection (74) and laser (74). There were fewer treatment failures after prostatic resection (p = 0.008) and fewer men after resection required secondary surgery for poor results (1 versus 7, p = 0.029). Maximum flow rates after transurethral prostatic resection were better than after laser (mean difference 4.4 ml. per second). Comparison of symptom and quality of life scores demonstrated that any clinically significant advantage for laser could be ruled out. Patients stayed a mean of 2 extra days in the hospital after resection. The duration of catheterization was greater after laser but significantly fewer major treatment complications were found with laser therapy.
CONCLUSIONS: Transurethral prostatic resection was more effective, resulted in fewer failures than laser treatment and remains the procedure of choice for men with acute urinary retention.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435848

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Holmium laser enucleation of the prostate: a paradigm shift in benign prostatic hyperplasia surgery.

Authors:  Tevita F Aho
Journal:  Ther Adv Urol       Date:  2013-10

Review 2.  Systematic review and meta-analysis on management of acute urinary retention.

Authors:  P D Yoon; V Chalasani; H H Woo
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-07-21       Impact factor: 5.554

3.  Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomised controlled trial.

Authors:  Sara T Brookes; Jenny L Donovan; Tim J Peters; Paul Abrams; David E Neal
Journal:  BMJ       Date:  2002-05-04

4.  Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-08-01

5.  Does the Intensity of Cutting Power Affect Postoperative Symptoms During Transurethral Resection with a Monopolar System?

Authors:  Mustafa Kirac; Çagrı Guneri; Nuri Deniz; Hasan Biri
Journal:  Indian J Surg       Date:  2013-06-19       Impact factor: 0.656

6.  Changes in surgical strategy for patients with benign prostatic hyperplasia: 12-year single-center experience.

Authors:  Yu Seob Shin; Jong Kwan Park
Journal:  Korean J Urol       Date:  2011-03-18

7.  A randomized controlled trial of neuromuscular electrical stimulation for chronic urinary retention following traumatic brain injury.

Authors:  Yong-Bing Zhang; Yan-Na Cheng
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.